10 20 30 40 50 60 70 80 1ZGB - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 21-APR-05 1ZGB
TITLE CRYSTAL STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN TITLE 2 COMPLEX WITH AN (R)-TACRINE(10)-HUPYRIDONE INHIBITOR.
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACHE; COMPND 5 EC: 3.1.1.7
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TORPEDO CALIFORNICA; SOURCE 3 ORGANISM_COMMON: PACIFIC ELECTRIC RAY; SOURCE 4 ORGANISM_TAXID: 7787
KEYWDS SERINE-HYDROLASE, PROTEIN-INHIBITOR COMPLEX, ENANTIOMERIC KEYWDS 2 SELECTIVITY, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, STRUCTURAL KEYWDS 3 GENOMICS, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR H.HAVIV,D.M.WONG,H.M.GREENBLATT,P.R.CARLIER,Y.P.PANG,I.SILMAN, AUTHOR 2 J.L.SUSSMAN,ISRAEL STRUCTURAL PROTEOMICS CENTER (ISPC)
REVDAT 3 13-JUL-11 1ZGB 1 VERSN REVDAT 2 24-FEB-09 1ZGB 1 VERSN REVDAT 1 16-AUG-05 1ZGB 0
JRNL AUTH H.HAVIV,D.M.WONG,H.M.GREENBLATT,P.R.CARLIER,Y.P.PANG, JRNL AUTH 2 I.SILMAN,J.L.SUSSMAN JRNL TITL CRYSTAL PACKING MEDIATES ENANTIOSELECTIVE LIGAND RECOGNITION JRNL TITL 2 AT THE PERIPHERAL SITE OF ACETYLCHOLINESTERASE JRNL REF J.AM.CHEM.SOC. V. 127 11029 2005 JRNL REFN ISSN 0002-7863 JRNL PMID 16076210 JRNL DOI 10.1021/JA051765F
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.R.CARLIER,D.-M.DU,Y.-F.HAN,J.LIU,Y.-P.PANG REMARK 1 TITL POTENT, EASILY SYNTHESIZED HUPERZINE A-TACRINE HYBRID REMARK 1 TITL 2 ACETYLCHOLINESTERASE INHIBITORS REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 9 2335 1999 REMARK 1 REFN ISSN 0960-894X REMARK 1 PMID 10476864 REMARK 1 DOI 10.1016/S0960-894X(99)00396-0 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.M.WONG,H.M.GREENBLATT,H.DVIR,P.R.CARLIER,Y.-F.HAN, REMARK 1 AUTH 2 Y.-P.PANG,I.SILMAN,J.L.SUSSMAN REMARK 1 TITL ACETYLCHOLINESTERASE COMPLEXED WITH BIVALENT LIGANDS RELATED REMARK 1 TITL 2 TO HUPERZINE A: EXPERIMENTAL EVIDENCE FOR SPECIES-DEPENDENT REMARK 1 TITL 3 PROTEIN-LIGAND COMPLEMENTARITY REMARK 1 REF J.AM.CHEM.SOC. V. 125 363 2003 REMARK 1 REFN ISSN 0002-7863 REMARK 1 PMID 12517147 REMARK 1 DOI 10.1021/JA021111W REMARK 1 REFERENCE 3 REMARK 1 AUTH M.L.RAVES,M.HAREL,Y.-P.PANG,I.SILMAN,A.P.KOZIKOWSKI, REMARK 1 AUTH 2 J.L.SUSSMAN REMARK 1 TITL STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH THE REMARK 1 TITL 2 NOOTROPIC ALKALOID, (-)-HUPERZINE A REMARK 1 REF NAT.STRUCT.BIOL. V. 4 57 1997 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 8989325 REMARK 1 DOI 10.1038/NSB0197-57 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.L.SUSSMAN,M.HAREL,F.FROLOW,C.OEFNER,A.GOLDMAN,L.TOKER, REMARK 1 AUTH 2 I.SILMAN REMARK 1 TITL ATOMIC STRUCTURE OF ACETYLCHOLINESTERASE FROM TORPEDO REMARK 1 TITL 2 CALIFORNICA: A PROTOTYPIC ACETYLCHOLINE-BINDING PROTEIN REMARK 1 REF SCIENCE V. 253 872 1991 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 1678899
REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1962219.640 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 43555 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2190 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6902 REMARK 3 BIN R VALUE (WORKING SET) : 0.2180 REMARK 3 BIN FREE R VALUE : 0.2550 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 315 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4175 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 178 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.66000 REMARK 3 B22 (A**2) : 7.66000 REMARK 3 B33 (A**2) : -15.32000 REMARK 3 B12 (A**2) : 5.56000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.23 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.116 REMARK 3 BOND ANGLES (DEGREES) : 1.90 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.38 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.267 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.959 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.169 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.028 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 35.49 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ARE.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ARE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1ZGB COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-APR-05. REMARK 100 THE RCSB ID CODE IS RCSB032686.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-SEP-00 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC BLUE CONFOCAL MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : STRATEGY REMARK 200 DATA SCALING SOFTWARE : CCP4 (TRUNCATE) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44250 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 1.590 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 10.00 REMARK 200 R MERGE FOR SHELL (I) : 0.36700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: XTALVIEW REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 200, PH 5.8, TEMPERATURE 277K, REMARK 280 VAPOR DIFFUSION, HANGING DROP. PROTEIN WAS CRYSTALLISED FROM 28% REMARK 280 V/V PEG 200 0.5 M MES PH 5.8 AT 277K, SEEDING WITH TRIGONAL REMARK 280 MICROCRYSTALS; THEN SOAKED IN MOTHER LIQUOR (40% V/V PEG 200 IN REMARK 280 0.1 M MES BUFFER, PH 5.8) CONTAINING 2 MM (RS)-(+/-)- TACRINE(10) REMARK 280 -HUPYRIDONE ((5RS)-(+/-)-5-{[10-(1,2,3,4-TETRAHYDROACRIDIN-9- REMARK 280 YLAMINO) DECYL] AMINO}-5,6,7,8-TETRAHYDRO-QUINOLIN-2(1H)-ONE) BIS REMARK 280 -OXALATE FOR 17 HOURS.
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.69833 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 91.39667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 91.39667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.69833 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 55.72450 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 96.51767 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 45.69833
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ASP A 2 REMARK 465 HIS A 3 REMARK 465 HIS A 486 REMARK 465 SER A 487 REMARK 465 GLN A 488 REMARK 465 GLU A 489 REMARK 465 ALA A 536 REMARK 465 CYS A 537 REMARK 465 ASP A 538 REMARK 465 GLY A 539 REMARK 465 GLU A 540 REMARK 465 LEU A 541 REMARK 465 SER A 542 REMARK 465 SER A 543
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 7 CD2 REMARK 470 ILE A 27 CD1 REMARK 470 MET A 43 CE REMARK 470 LYS A 52 CD CE NZ REMARK 470 LYS A 192 NZ REMARK 470 ARG A 250 CZ NH1 NH2 REMARK 470 GLU A 260 OE2 REMARK 470 GLU A 261 OE1 REMARK 470 LYS A 270 NZ REMARK 470 GLU A 344 OE2 REMARK 470 GLU A 350 CD OE1 OE2 REMARK 470 LYS A 413 CD CE NZ REMARK 470 GLU A 434 OE1 REMARK 470 LYS A 454 CG CD CE NZ REMARK 470 LYS A 498 CD CE NZ REMARK 470 GLU A 508 OE1 OE2 REMARK 470 LYS A 511 CD CE NZ REMARK 470 ARG A 515 NH1 NH2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE ARG A 349 O HOH A 4296 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 22 CB - CA - C ANGL. DEV. = -12.1 DEGREES REMARK 500 ARG A 221 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG A 243 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 VAL A 518 CB - CA - C ANGL. DEV. = -15.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 25 -157.62 -133.35 REMARK 500 PHE A 45 -13.59 81.25 REMARK 500 CYS A 94 11.48 -140.81 REMARK 500 SER A 108 76.77 -162.23 REMARK 500 SER A 200 -124.50 58.95 REMARK 500 GLU A 299 -73.54 -115.07 REMARK 500 THR A 317 -161.64 -160.99 REMARK 500 ASP A 380 52.34 -157.08 REMARK 500 VAL A 400 -59.45 -130.48 REMARK 500 ASN A 506 -163.03 -160.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 442 0.06 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LYS A 491 24.5 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 591 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 4161 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A1E A 1001
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZGC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN IN COMPLEX WITH AN REMARK 900 (RS)-TACRINE(10)HUPYRIDONE INHIBITOR REMARK 900 RELATED ID: W00568 RELATED DB: TARGETDB
DBREF 1ZGB A 1 543 UNP P04058 ACES_TORCA 22 564
SEQRES 1 A 543 ASP ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY SEQRES 2 A 543 LYS VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS SEQRES 3 A 543 ILE SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO SEQRES 4 A 543 VAL GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS SEQRES 5 A 543 PRO TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN SEQRES 6 A 543 ASN CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SEQRES 7 A 543 SER GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER SEQRES 8 A 543 GLU ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO SEQRES 9 A 543 ARG PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY SEQRES 10 A 543 GLY GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR SEQRES 11 A 543 ASN GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU SEQRES 12 A 543 VAL SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU SEQRES 13 A 543 ALA LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY SEQRES 14 A 543 LEU LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP SEQRES 15 A 543 ASN ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR SEQRES 16 A 543 ILE PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET SEQRES 17 A 543 HIS ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG SEQRES 18 A 543 ALA ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA SEQRES 19 A 543 SER VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU SEQRES 20 A 543 LEU GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU SEQRES 21 A 543 GLU LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU SEQRES 22 A 543 LEU ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER SEQRES 23 A 543 ILE PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU SEQRES 24 A 543 PHE PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY SEQRES 25 A 543 ASN PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS SEQRES 26 A 543 ASP GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY SEQRES 27 A 543 PHE SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP SEQRES 28 A 543 PHE MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN SEQRES 29 A 543 ASP LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP SEQRES 30 A 543 TRP MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY SEQRES 31 A 543 LEU ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO SEQRES 32 A 543 LEU MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN SEQRES 33 A 543 GLY THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN SEQRES 34 A 543 LEU VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR SEQRES 35 A 543 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU SEQRES 36 A 543 LEU ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG SEQRES 37 A 543 ILE MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN SEQRES 38 A 543 PRO ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU SEQRES 39 A 543 PHE THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR SEQRES 40 A 543 GLU PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET SEQRES 41 A 543 CYS VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN SEQRES 42 A 543 ALA THR ALA CYS ASP GLY GLU LEU SER SER
MODRES 1ZGB ASN A 59 ASN GLYCOSYLATION SITE MODRES 1ZGB ASN A 416 ASN GLYCOSYLATION SITE
HET NAG A 591 14 HET NAG A4161 14 HET A1E A1001 37
HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM A1E (5R)-5-{[10-(1,2,3,4-TETRAHYDROACRIDIN-9-YLAMINO) HETNAM 2 A1E DECYL]AMINO}-5,6,7,8-TETRAHYDROQUINOLIN-2(1H)-ONE
HETSYN A1E (R)-N-9 -(1 ,2 ,3 ,4 -TETRAHYDROACRIDINYL)-N'-5 -[5 ,6 HETSYN 2 A1E ,7 ,8 -TETRAHYDRO-2'(1'H)-QUINOLINONYL]-1,10- HETSYN 3 A1E DIAMINODECANE; (R)-TACRINE(10)-HUPYRIDONE
FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 4 A1E C32 H44 N4 O FORMUL 5 HOH *178(H2 O)
HELIX 1 1 VAL A 40 ARG A 44 5 5 HELIX 2 2 PHE A 78 MET A 83 1 6 HELIX 3 3 LEU A 127 ASN A 131 5 5 HELIX 4 4 GLY A 132 GLU A 140 1 9 HELIX 5 5 VAL A 150 LEU A 156 1 7 HELIX 6 6 ASN A 167 ILE A 184 1 18 HELIX 7 7 GLN A 185 PHE A 187 5 3 HELIX 8 8 SER A 200 SER A 212 1 13 HELIX 9 9 SER A 215 PHE A 219 5 5 HELIX 10 10 VAL A 238 LEU A 252 1 15 HELIX 11 11 SER A 258 LYS A 269 1 12 HELIX 12 12 LYS A 270 GLU A 278 1 9 HELIX 13 13 TRP A 279 LEU A 282 5 4 HELIX 14 14 SER A 304 GLY A 312 1 9 HELIX 15 15 GLY A 328 ALA A 336 1 9 HELIX 16 16 SER A 348 VAL A 360 1 13 HELIX 17 17 ASN A 364 THR A 376 1 13 HELIX 18 18 ASN A 383 VAL A 400 1 18 HELIX 19 19 VAL A 400 GLY A 415 1 16 HELIX 20 20 PRO A 433 GLY A 437 5 5 HELIX 21 21 GLU A 443 PHE A 448 1 6 HELIX 22 22 GLY A 449 ASN A 457 5 9 HELIX 23 23 THR A 459 GLY A 480 1 22 HELIX 24 24 ARG A 517 GLN A 526 1 10 HELIX 25 25 GLN A 526 THR A 535 1 10
SHEET 1 A 3 LEU A 7 THR A 10 0 SHEET 2 A 3 GLY A 13 MET A 16 -1 O VAL A 15 N VAL A 8 SHEET 3 A 3 VAL A 57 ASN A 59 1 O TRP A 58 N MET A 16 SHEET 1 B11 THR A 18 VAL A 22 0 SHEET 2 B11 SER A 25 PRO A 34 -1 O ILE A 27 N VAL A 20 SHEET 3 B11 TYR A 96 VAL A 101 -1 O ILE A 99 N PHE A 30 SHEET 4 B11 VAL A 142 SER A 145 -1 O SER A 145 N ASN A 98 SHEET 5 B11 THR A 109 ILE A 115 1 N MET A 112 O VAL A 144 SHEET 6 B11 GLY A 189 GLU A 199 1 O ASP A 190 N THR A 109 SHEET 7 B11 ARG A 221 GLN A 225 1 O GLN A 225 N GLY A 198 SHEET 8 B11 GLN A 318 ASN A 324 1 O LEU A 320 N LEU A 224 SHEET 9 B11 GLY A 417 PHE A 423 1 O PHE A 423 N VAL A 323 SHEET 10 B11 LYS A 501 LEU A 505 1 O LEU A 505 N PHE A 422 SHEET 11 B11 VAL A 512 GLN A 514 -1 O HIS A 513 N PHE A 502 SHEET 1 C 2 VAL A 236 SER A 237 0 SHEET 2 C 2 VAL A 295 ILE A 296 1 O ILE A 296 N VAL A 236
SSBOND 1 CYS A 67 CYS A 94 1555 1555 2.07 SSBOND 2 CYS A 254 CYS A 265 1555 1555 2.03 SSBOND 3 CYS A 402 CYS A 521 1555 1555 2.04
LINK ND2 ASN A 59 C1 NAG A 591 1555 1555 1.48 LINK ND2 ASN A 416 C1 NAG A4161 1555 1555 1.45
CISPEP 1 SER A 103 PRO A 104 0 0.74
SITE 1 AC1 2 ASN A 59 SER A 61 SITE 1 AC2 3 ASN A 416 HOH A4224 HOH A4304 SITE 1 AC3 13 LYS A 11 TRP A 84 GLY A 118 TYR A 121 SITE 2 AC3 13 GLN A 185 GLU A 199 TRP A 279 PHE A 330 SITE 3 AC3 13 TYR A 334 TRP A 432 HIS A 440 HOH A4289 SITE 4 AC3 13 HOH A4335
CRYST1 111.449 111.449 137.095 90.00 90.00 120.00 P 31 2 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008973 0.005180 0.000000 0.00000
SCALE2 0.000000 0.010361 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007294 0.00000